Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients (2007)
- Autores:
- Autores USP: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU
- Unidades: FCF; HU
- Assuntos: HIPERCOLESTEROLEMIA; EXPRESSÃO GÊNICA; FARMACOGENÉTICA
- Idioma: Inglês
- Imprenta:
- Editora: International Pharmaceutical Federation
- Local: Amsterdam
- Data de publicação: 2007
- Fonte:
- Título do periódico: Abstracts
- Nome do evento: World Congress of the Board of Pharmaceutical Sciences of FIP
-
ABNT
ARAZI, Simone Sorkin et al. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. 2007, Anais.. Amsterdam: International Pharmaceutical Federation, 2007. . Acesso em: 16 abr. 2024. -
APA
Arazi, S. S., Willrich, M. A. V., Dalla-Vecchia, F., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2007). Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. In Abstracts. Amsterdam: International Pharmaceutical Federation. -
NLM
Arazi SS, Willrich MAV, Dalla-Vecchia F, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. Abstracts. 2007 ;[citado 2024 abr. 16 ] -
Vancouver
Arazi SS, Willrich MAV, Dalla-Vecchia F, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. Abstracts. 2007 ;[citado 2024 abr. 16 ] - CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin down-regulates ABCA1 gene expression in peripheral blood mononuclear cells of Brazilian hyper-cholesterolemic patients
- Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
- Efeitos de polimorfismo genético do SREBF1 sobre o perfil lipídico sérico de indivíduos sob terapia hipolipemiante
- Efeito da atorvastatina sobre os genes SREBF1, SREBF2 e SCAP em pacientes hipercolesterolêmicos
- Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
- Resposta hipolipemiante à atorvastatina é modificada pelo polimorfismo do gene da CYP3A5
- Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
